Product Images Divalproex Sodium Delayed-release
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Divalproex Sodium Delayed-release NDC 53808-0681 by State Of Florida Doh Central Pharmacy, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is the label for Divalproex Sodium Delayed-Release Tablets, USP 500 mg 30 tablets. - Divalpoex Sod 500mg Qualitest
Structural formula of Divalproex Sodium Delayed Release Tablets. - divalproexdr 1
Figure 1. Percentage of Patients Achieving ≥ 30% Reduction in Symptom Score From Baseline - divalproexdr 2
The text describes the percentage of patients achieving more than a 30% reduction in symptoms compared to their baseline, represented in Figure 1. The data from Study 1 and 2 are shown for treatments with placebo and divalproex sodium. The asterisk (*) denotes statistical significance with p<0.05.*
Figure 2 - divalproexdr 3
This appears to be a chart showing the percentage reduction in CPS (cycles per second) rate for divalproex sodium versus a placebo. The chart displays various percentages ranging from -100% to 100%. Additionally, there is a bar graph displaying the percentage of patients who experienced improvement, no change, or worsening of symptoms with divalproex sodium.*
Figure 3 - divalproexdr 4
The text is a graph showing the reduction in CPS (Central Precocious Puberty) rate with two different drug doses. The graph has different percentage values ranging from 100% to -100%, along with a scale showing the percentage of patients who experienced improvement, no change or worsening.*
Figure 4. Mean 4-week Migraine Rates - divalproexdr 5
The figure shows the mean 4-week migraine rates for Placebo and Divalproex Sodium in Study 1 and Study 2. The mean dose of Divalproex Sodium was either 500 or 1,000 mg/day in Study 2, while in Study 1 it was 1,087 mg/day.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.